Global Village participants
GV1: Delegation of Oregon, USA
Round table discussion: Tue, May 6, 14:00 – 14:30, Eventhall stage
Title: Oregon and Switzerland have formed a new Journey of Collaboration
GV2: Delegation of Spain
Round table discussion: Mo, May 5, 14:15 – 15:00, Eventhall stage
Title: tba
GV3: Delegation of Japan
Round table discussion: Mo, May 5, 16:00 – 16:30, Eventhall stage
Title: Swiss-Japanese Biotech Synergies: Innovation, Expansion & Partnership across Borders
GV4: Delegation of Brazil
–
GV5: Delegation of China
Round table discussion: Tu, May 6, 14:45 – 15:15, Eventhall stage
Title: From China’s AI Surge to Switzerland’s Pharma Leadership: Accelerating the Sino–Swiss Strategy for Global Impact in Life Sciences
GV6: Delegation of Italy
–
GV7: Delegation of India
Round table discussion: Tu, May 6, 14:00 – 14:30, Eventhall stage
Title: From India to the World: Biotech Bridges with Swiss Expertise
GV8: Delegation of Iran
–
GV9: Delegation of Belgium
–
GV10: Delegation of the Netherlands
Round table discussion: Tue, May 6, 12:00 – 12:45, Eventhall stage
Titel: Organ-on-Chip: Implementation through Collaboration between the Netherlands and Switzerland
Global Village participants
GV11: Delegation of the Nordic countries
Round table discussion: Mo, May 5, 15:15 – 15:45, Eventhall stage
Title: The Nordics and Switzerland innovating together: Translating Innovation into Biotech Ventures
GV12: Delegation of North Carolina, USA
–
GV13: Delegation of Estonia
Round table discussion: Tu, May 6, 14:45 – 15:15, room Verseau
Title: Building large scale digital Infrastructure for Healthcare Systems
GV14: Delegation of the Heidelberg–Mannheim region, Germany – bioRN Life Science Cluster
–
GV15: Delegation of Rhineland-Palatinate, Germany
–
GV16: Delegation of Czechia
–
GV17: Delegation of Taiwan
–
GV19: Delegation of Bavaria, Germany
Round table discussion: Tue, May 6, 13:00 – 13:45, Eventhall stage
Title: Bridging Ecosystems: Empowering Startups from Pre-Seed to Scale-Up in Bavaria and Switzerland (4 Case Studies)
GV20: Delegation of Saxony, Germany
–
GV21: Delegation of Hong Kong
–
GV22: Delegation of Canada
Round table discussion: Mo, May 5, 16:45 – 17:15, Eventhall stage
Title: tba
GV23: Delegation of Australia
–
GV24: Delegation of South Korea
Tuesday, May 6, 2025, 09:00-09:45
Eureka: funding for global R&D cooperation
This plenary session will spotlight EUREKA, the world’s largest public network for international R&D and innovation, with a presence in over 45 countries. It will feature an introduction by the EUREKA Secretariat, followed by a discussion and testimonies from international biotech companies and EUREKA representatives. Moderated by Innosuisse, the session will include audience questions and conclude with an outlook on the Swiss Biotech Day 2026 and the Eureka Global Innovation Summit 2026.
Moderator: Andreas Gut, Innosuisse
Floor map
An interactive floor map is available to help you locate booths, session rooms, and partnering areas. Please click on the button below.